Clinical Studies of Safety and Effectiveness of Orphan Products; Availability of Grants; Request for Applications

الملخص

The Food and Drug Administration (FDA) is announcing changes to its Orphan Products Development (OPD) grant program for fiscal year (FY) 2002. This announcement supersedes the previous announcement of this program, which was published in the Federal Register of August 8, 2000.